Lymphocyte Subpopulations in Patients With Neurofibromatosis Type 1-associated Optic Pathway Gliomas and Plexiform Neurofibromas.

Anticancer Res

Department of Pediatric Hematology and Oncology, Nicolaus Copernicus University Torun, Jurasz University Hospital, Collegium Medicum, Bydgoszcz, Poland.

Published: November 2019

AI Article Synopsis

Article Abstract

Background/aim: Neurofibromatosis type 1 (NF1) is characterized by the occurrence of multisystem tumors, among which the most characteristic are optic pathway gliomas (OPGs) and plexiform neurofibromas (PNFs). With the development of new anticancer drugs targeting the immune system, it is important to examine the immunological status of patients with NF1. Furthermore, the immune system has been suggested as a probable modulator of NF1-associated phenotypes. The objective of this study was the analysis of lymphocyte subset populations with respect to the presence of PNFs and OPGs.

Patients And Methods: Fifty-three patients with NF1 diagnosed with OPG/PNF were analyzed for lymphocyte subpopulations.

Results: Significantly lower levels of B-cells, T-cells and natural killer (NK) cells were observed in the group of patients with PNFs compared to those with OPG.

Conclusion: Our observation may indicate a correlation between weakened functioning of the immune system and the formation of PNFs.

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.13852DOI Listing

Publication Analysis

Top Keywords

immune system
12
neurofibromatosis type
8
optic pathway
8
pathway gliomas
8
plexiform neurofibromas
8
patients nf1
8
lymphocyte subpopulations
4
patients
4
subpopulations patients
4
patients neurofibromatosis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!